• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

验证波兰版帕金森病胃肠道功能障碍量表。

Validation of Polish version of Gastrointestinal Dysfunction Scale for Parkinson's Disease.

机构信息

Nekon' Student Scientific Group, Department of Neurology, Faculty of Health Science, Medical University of Warsaw, Warsaw, Poland.

Department of Neurology, Faculty of Health Sciences, Medical University of Warsaw, Warsaw, Poland.

出版信息

Neurol Neurochir Pol. 2024;58(3):338-346. doi: 10.5603/pjnns.98275. Epub 2024 Jun 7.

DOI:10.5603/pjnns.98275
PMID:38845557
Abstract

AIM OF STUDY

The Gastrointestinal Dysfunction Scale for Parkinson's Disease (GIDS-PD) is a novel, disease-specific self-report questionnaire used to quantitatively assess features of gastrointestinal dysfunction symptoms in patients with Parkinson's Disease. The aim of this paper was to validate the Polish translation of the scale, to summarise its consistency with the English language version, and to assess its clinimetric properties.

CLINICAL RATIONALE FOR STUDY

Gastrointestinal dysfunction is a common and often debilitating manifestation of Parkinson's Disease (PD). Gastrointestinal symptoms are also considered to be prodromal features of this disease. To date, there has been no scale in Polish that has precisely assessed gastrointestinal symptoms in patients with PD.

MATERIAL AND METHODS

The GIDS-PD was translated into Polish by two investigators (M.K. and J.N.). A back-translation was completed by two separate investigators (M.F. and A.A.) who were not involved in the original translation. Afterwards, 10 Polish PD patients underwent cognitive pre-testing. After the final translation was officially approved by the Movement Disorder Society, it was tested on 64 individuals with PD during field testing. For the purpose of testing scale reliability, 20 of the patients recruited for field testing underwent the GIDS-PD for a second time after 8-12 weeks.

RESULTS

The GIDS-PD demonstrated overall good consistency (Cronbach's alpha of 0.74, ICC of 0.74). Regarding the individual domains, the constipation subscore demonstrated good reliability, the bowel irritability subscore demonstrated moderate reliability, and the upper GI subscore demonstrated poor reliability. Upper GI symptoms seem to be less pronounced, and also more varied, in the Polish PD population than in its English language counterpart.

CONCLUSIONS AND CLINICAL IMPLICATIONS

This paper provides a validated Polish translation of the GIDS-PD questionnaire. We highly recommend using the GIDS-PD for research purposes, as well as everyday clinical practice in the Polish PD population.

摘要

研究目的

帕金森病胃肠功能障碍量表(GIDS-PD)是一种新颖的、针对特定疾病的自我报告问卷,用于定量评估帕金森病患者胃肠功能障碍症状的特征。本文的目的是验证该量表的波兰语翻译版本,总结其与英语版本的一致性,并评估其临床计量特性。

研究的临床意义

胃肠功能障碍是帕金森病(PD)常见且常使人衰弱的表现。胃肠症状也被认为是这种疾病的前驱特征。迄今为止,波兰语中还没有一种量表能够精确评估 PD 患者的胃肠症状。

材料和方法

两位研究人员(M.K.和 J.N.)将 GIDS-PD 翻译成波兰语。两名独立的研究人员(M.F.和 A.A.)完成了反向翻译,他们没有参与原始翻译。之后,10 名波兰 PD 患者进行了认知预测试。在最终翻译得到运动障碍协会正式批准后,在现场测试中对 64 名 PD 患者进行了测试。为了测试量表的可靠性,招募了 20 名现场测试患者,在 8-12 周后对他们进行了第二次 GIDS-PD 测试。

结果

GIDS-PD 总体上显示出良好的一致性(Cronbach's alpha 为 0.74,ICC 为 0.74)。就个别领域而言,便秘子量表的可靠性较好,肠易激惹子量表的可靠性为中等,上胃肠道子量表的可靠性较差。与英语语言的 PD 患者相比,波兰语 PD 患者的上胃肠道症状似乎不太明显,也更为多样化。

结论和临床意义

本文提供了 GIDS-PD 问卷的验证性波兰语翻译。我们强烈推荐在波兰语 PD 人群中使用 GIDS-PD 进行研究目的以及日常临床实践。

相似文献

1
Validation of Polish version of Gastrointestinal Dysfunction Scale for Parkinson's Disease.验证波兰版帕金森病胃肠道功能障碍量表。
Neurol Neurochir Pol. 2024;58(3):338-346. doi: 10.5603/pjnns.98275. Epub 2024 Jun 7.
2
Polish validation of Parkinson's Disease non-motor questionnaire and clinical use in real life PD patients.
Neurol Neurochir Pol. 2025;59(2):177-182. doi: 10.5603/pjnns.102113. Epub 2025 Apr 7.
3
Validation of the Polish version of the Movement Disorder Society-Unified Parkinson's Disease Rating Scale (MDS-UPDRS).验证波兰版运动障碍协会-统一帕金森病评定量表(MDS-UPDRS)。
Neurol Neurochir Pol. 2020;54(5):416-425. doi: 10.5603/PJNNS.a2020.0049. Epub 2020 Jul 8.
4
The Gastrointestinal Dysfunction Scale for Parkinson's Disease.帕金森病胃肠功能障碍量表。
Mov Disord. 2021 Oct;36(10):2358-2366. doi: 10.1002/mds.28675. Epub 2021 Jun 16.
5
Gastrointestinal Manifestations in Parkinson's Disease Using a Validated Arabic Version of Gastrointestinal Dysfunction Scale: A Multicenter Study.使用经过验证的阿拉伯语版胃肠功能障碍量表对帕金森病患者胃肠道表现的多中心研究
Mov Disord Clin Pract. 2025 Mar 15. doi: 10.1002/mdc3.70005.
6
Validation of the Polish version of the Unified Dyskinesia Rating Scale (UDysRS).验证波兰版统一运动障碍评分量表(UDysRS)。
Neurol Neurochir Pol. 2021;55(2):186-194. doi: 10.5603/PJNNS.a2021.0010. Epub 2021 Feb 2.
7
Dysautonomia rating scales in Parkinson's disease: sialorrhea, dysphagia, and constipation--critique and recommendations by movement disorders task force on rating scales for Parkinson's disease.帕金森病自主神经功能障碍评定量表:流涎、吞咽困难和便秘——帕金森病评定量表运动障碍特别工作组的评论与建议
Mov Disord. 2009 Apr 15;24(5):635-46. doi: 10.1002/mds.22260.
8
Validation of the Portuguese version of the Movement Disorder Society non-motor rating scale (MDS-NMS) in Parkinson's disease.帕金森病中运动障碍协会非运动评定量表(MDS-NMS)葡萄牙语版本的验证
Parkinsonism Relat Disord. 2025 Mar;132:107276. doi: 10.1016/j.parkreldis.2025.107276. Epub 2025 Jan 13.
9
Expanded and independent validation of the NoMoFA scale for Parkinson's disease: the Italian version.帕金森病NoMoFA量表的扩展与独立验证:意大利语版本
J Neurol. 2024 Dec 28;272(1):89. doi: 10.1007/s00415-024-12863-7.
10
Validation of the Bulgarian version of Scales for Outcomes in Parkinson's Disease - Autonomic (SCOPA-AUT-BG).帕金森病自主神经功能障碍量表保加利亚语版(SCOPA-AUT-BG)的验证
Folia Med (Plovdiv). 2013 Jul-Dec;55(3-4):56-62. doi: 10.2478/folmed-2013-0028.

引用本文的文献

1
Radiosurgical thalamotomy for the management of tremors: a systematic review and meta-analysis.用于治疗震颤的放射外科丘脑切开术:一项系统评价和荟萃分析。
Neurol Sci. 2025 Jan;46(1):79-88. doi: 10.1007/s10072-024-07670-x. Epub 2024 Jul 5.